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SARS-CoV-2 spike (S) glycoprotein is the key target of current vaccine development 
efforts to combat Covid-19. Neutralizing antibodies bind S and interfere with S binding 
to its receptor, angiotensin-converting enzyme 2 (ACE2). Recent work reveals the 
molecular basis of increased infectivity of the now globally prevailing D614G S 
mutation1.  
The SARS-CoV-2 pandemic is a global crisis causing countless deaths and economic damage 
world-wide, vastly surpassing the previous SARS-CoV outbreak 2002-2004. SARS-CoV-2 S 
glycoprotein is cleaved into S1 and S2 subunits enabling fusion of virus and host cell 
membranes. SARS-CoV-2 S has higher affinity for ACE2 as compared to SARS-CoV S due 
to six mutations in the receptor-binding motif (RBM)2,3. Moreover, SARS-CoV-2 S acquired a 
furin cleavage site between S1 and S2 (Fig.1), thought to promote pathogeneicity4. ACE2 
binding triggers conformational changes that allow host proteases to further cleave S2, 
followed by shedding of S1 and activation of drastic S2 refolding into a post-fusion state5.  
For cryo-EM and functional studies, different strategies were followed to stabilize the prefusion 
SARS-CoV-2 S trimer: mutation or deletion of the furin cleavage site, two proline (2P) 
mutations in S2 (K986P, V987P) and a C-terminal trimerization domain which replaces the 
transmembrane domain and cytoplasmic C-terminus of wild-type S2,3. Numerous S structures 
were determined, revealing a highly dynamic protein: S receptor-binding domains (RBD) 
undergo hinge-like movements to switch between ‘down’ and ‘up’ conformations; ‘up’ is 
compatible with ACE2-binding while the RBM is tucked away in the ‘down’ conformation. 50% 
to 70% open conformation (RBDs up-down-down) were observed for S, along with 30-50% 
closed trimer (RBDs all-down) in cryo-EM samples, with the open form thought to mediate 
infectivity2,3. The structure of S with a native furin site, stabilized by the 2P mutation, 
highlighted the impact of cleavage4: while in the uncleaved form ~83% of S was in a closed 
conformation, only 34% were closed in furin-cleaved S. The remaining particles adopted 
intermediate (one RBD disordered) and open conformations (up-down-down). Overall, furin 
cleavage facilitates the movement of S1 RBDs and N-terminal domains (NTDs), leading to 
lower thermal stability and more receptor-binding competent forms of S. 
Since the outbreak of the Covid-19 pandemic, only a few mutations reached high global 
frequency. One of these mutations is the D614G mutation in S which became dominant during 
the pandemic, virtually replacing the ancestral S. D614G spike is associated with increased 
infectivity and viral load in patients with Covid-191. Yurkovetskiy and colleagues1 shed light on 
the molecular mechanism leading to dramatic changes in S structure and dynamics, caused 
by just a single mutation: the D614G S-trimer structure, stabilized in this study by deletion of 
the furin site and 2P mutations, revealed a preponderance of open conformations (~95%). In 
addition to the up-down-down open conformation, also 2RBDs-up and 3RBDs-up 
conformations were observed1. The authors determined a decreased affinity of D614G for 
ACE2 which appears to be compensated for by the presence of many more receptor-binding 
competent RBDs. Residue D614 is positioned in subdomain SD2 and forms a hydrogen bond 
to T859 in S21, stabilizing the S1-S2 interface. In D614G, the inter-protomer hydrogen bond is 
replaced by an intra-SD2 interaction. Globally, D614G destabilization of the S1-S2 interface 
triggers S1 domains moving away from the S-trimer axis and RBD opening, likely leading to 
increased ACE2-binding and elevated viral infectivity. 
These findings agree with studies describing subdomains SD1 and SD2 of S1 as a hinge for 
RBD up-movement6,7. Henderson and colleagues introduced four hydrophobic mutations at 
the SD1-S2 interface to destabilize the interface and increase S1 mobility. The structure of 
this mutant indeed showed a prevalence of 1RBD-up and 2RBDs-up conformations6. Similarly, 




and destabilization of the S1-trimer7. In the presence of ACE2, more open RBD conformations 
(2RBDs-up and 3RBDs-up) were observed and are thought to be on pathway for virion-host 
cell membrane fusion and cell entry. Also, ACE2-binding was shown to induce SD2 refolding 
which disrupt sidechain -stacking interactions between SD2 and S2 and a salt bridge 
between D614 and K854 (rather than T8591)7. Moreover, a region in S2 proximal to the S2’ 
cleavage site becomes disordered, potentially exposing it7. Based on this, the D614G mutation 
likely facilitates SD2 rearrangements and destabilizes the closed conformation, thus 
increasing the likelihood of S trimers to adopt open conformations1,7.   
While furin cleavage and D164G mutation destabilize S, binding of a free fatty acid, linoleic 
acid (LA) to a pocket in the RBD stabilizes the trimer8. The cryo-EM structure of LA-bound S, 
stabilized by mutation of the furin-cleavage site, revealed a compact, locked S conformation 
adopted by ~70% of the trimers. In S, LA binds to three bipartite binding pockets, formed by 
adjacent RBDs, leading to RBD-trimer compaction incompatible with ACE2-binding. 
Consequently, LA-bound S had reduced affinity for ACE2 in vitro. In cell culture, LA synergized 
with remdesivir, an RNA-dependent RNA polymerase inhibitor, markedly suppressing SARS-
CoV-2 replication in human epithelial cells8, conveying that supplementation of LA or a LA-
mimic could be utilized as an antiviral to block virus replication.  
Neutralizing antibodies primarily interfere with ACE2-binding by S9. However, several potent 
neutralizing antibodies were reported to use a different mechanism, stabilizing the closed 
conformation by binding the NTD or the RBD-RBD interface9, rather than directly targeting the 
RBM. In comparison to above single-particle cryo-EM studies, cryo-tomography of intact 
SARS-CoV-2 virions, fixed with paraformaldehyde, found on average 26±15 S-trimers per 
virion of which ~54% were in the closed conformation10. 
Taken together, the current findings support the view that S proteins have evolved finely tuned 
mechanisms to reside in a metastable prefusion state, balancing RBM masking to avoid 
neutralization by the host immune response and its exposure which is necessary to enable 
ACE2 interaction and subsequent host cell infection. Mutations, proteolytic cleavage, or LA-
binding all affect the degrees of freedom of RBD-movement. In agreement, differences 
between different beta-coronavirus strains are clustered to domain interfaces6, underscoring 
that subtle changes in interdomain contacts determine RBD conformations with repercussions 










Figure 1. SARS-CoV-2 spike prefusion structure in a dynamic equilibrium between 
closed and open states. 
Above: Domain arrangement of SARS-CoV-2 S glycoprotein. S1 comprises a signal 
sequence, NTD, RBD, SD1 and SD2. S2 comprises a second cleavage site upstream of the 
fusion peptide, HR1, CH, CD, HR2, the TM domain and cytoplasmic C-terminus. NTD: N-
terminal domain; RBD: receptor-binding domain; SD1: subdomain 1; SD2: subdomain 2; S2’: 
second protease cleavage site; HR1: heptad repeat 1; CH: central helix; CD: connector 
domain; HR2: heptad repeat 2; TM: transmembrane domain. Cleavage sites are marked with 
arrow.  
Below: Closed (PDB ID: 6zb58) and open (PDB ID: 6zgg4) conformations of S are in a dynamic 
equilibrium which is shifted by mutations, proteolytic cleavage, binding of LA or antibodies. 
The open conformations, with one or more RBDs up, expose the receptor-binding motif (RBM, 
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